U.S. flag

An official website of the United States government

Abatacept

A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS.

Year introduced: 2016 (2002)

PubMed search builder options

Subheadings:

Tree Number(s): D12.776.124.790.651.114.580.225, D12.776.377.715.548.114.580.225

MeSH Unique ID: D000069594

Registry Number: 7D0YB67S97

Entry Terms:

  • Orencia
  • BMS 188667
  • BMS-188667
  • BMS188667
  • Belatacept
  • BMS224818
  • BMS-224818
  • BMS 224818
  • CTLA-4-Ig
  • CTLA4-Ig Immunoconjugate
  • CTLA4 Ig Immunoconjugate
  • Immunoconjugate, CTLA4-Ig
  • CTLA4-Fc
  • CTLA4-Ig
  • Cytotoxic T Lymphocyte-Associated Antigen 4-Immunoglobulin
  • Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin
  • LEA29Y
  • Nulojix

See Also:

Pharmacologic Action:

Supplemental Content

Loading ...
External link. Please review our privacy policy.